Cohomological tautness for Riemannian foliations

In this paper we present some new results on the tautness of Riemannian foliations in their historical context. The first part of the paper gives a short history of the problem. For a closed manifold, the tautness of a Riemannian foliation can be characterized cohomologically. We extend this cohomological characterization to a class of foliations which includes the foliated strata of any singular Riemannian foliation of a closed manifold

El cierre discursivo de los noticieros de televisión

In this article the television discourse is topicized from the analysis of the conditions that determine the competence ofthe television viewer in the active reception of television. Said competence is related with the capacity of critical reading of the media by the receptor. In order to evidentiate and qualify said competence, a model of reading television was designed, as initially applied to the informative genre, with which it was possible to consolidate a very significative exhibition or show about the characteristic way of developing the discourse of the media or medium in this type of programs. The considerations that are offered here enable the detection of the principal mechanisms that intervene in the discursive production of TV and its impact in opinion processes in the social surrounding or environment.En este artículo se tematiza el discurso televisivo a partir del análisis de las condiciones que determinan la competencia del televidente en la recepción activa de televisión. Dicha competencia se relaciona con la capacidad de lectura crítica del medio por parte del receptor. Para evidenciar y cualificar dicha competencia se diseñó un modelo de lectura de televisión, aplicado inicialmente al género informativo, con lo que se pudo consolidar una muestra significativa sobre el modo característico de desarrollarse el discurso del medio en este tipo de programas. Las consideraciones ofrecidas permiten detectar los principales mecanismos que intervienen en la producción discursiva de la televisión y su impacto en procesos de opinión en el ámbito social

Plasticity and cardiovascular applications of multipotent adult progenitor cells

Cardiovascular disease is the leading cause of death worldwide, which has encouraged the search for new therapies that enable the treatment of patients in palliative and curative ways. In the past decade, the potential benefit of transplantation of cells that are able to substitute for the injured tissue has been studied with several cell populations, such as stem cells. Some of these cell populations, such as myoblasts and bone marrow cells, are already being used in clinical trials. The laboratory of CM Verfaillie has studied primitive progenitors, termed multipotent adult progenitor cells, which can be isolated from adult bone marrow. These cells can differentiate in vitro at the single-cell level into functional cells that belong to the three germ layers and contribute to most, if not all, somatic cell types after blastocyst injection. This remarkably broad differentiation potential makes this particular cell population a candidate for transplantation in tissues in need of regeneration. Here, we focus on the regenerative capacity of multipotent adult progenitor cells in several ischemic mouse models, such as acute and chronic myocardial infarction and limb ischemia

Innovative Technologies for District Heating and Cooling: InDeal Project

The paper discusses the outcomes of the conference organized by the InDeal project. The conference took place on 12 December 2018 in Montpellier as part of the EnerGaia energy forum 2018. A holistic interdisciplinary approach for district heating and cooling (DHC) networks is presented that integrates heterogeneous innovative technologies from various scientific sectors. The solution is based on a multi-layer control and modelling framework that has been designed to minimize the total plant production costs and optimize heating/cooling distribution. Artificial intelligence tools are employed to model uncertainties associated with weather and energy demand forecasts, as well as quantify the energy storage capacity. Smart metering devices are utilized to collect information about all the crucial heat substations’ parameters, whereas a web-based platform offers a unique user environment for network operators. Three new technologies have been further developed to improve the efficiency of pipe design of DHC systems: (i) A new sustainable insulation material for reducing heat losses, (ii) a new quick-fit joint for an easy installation, and (iii) a new coating for reducing pressure head losses. The results of a study on the development and optimization of two energy harvesting systems are also provided. The assessment of the environmental, economic and social impact of the proposed holistic approach is performed through a life cycle analysis. The validation methodology of the integrated solution is also described, whereas conclusions and future work are finally given

Ontology Design Patterns for bio-ontologies: a case study on the Cell Cycle Ontology

<p>Abstract</p> <p>Background</p> <p>Bio-ontologies are key elements of knowledge management in bioinformatics. Rich and rigorous bio-ontologies should represent biological knowledge with high fidelity and robustness. The richness in bio-ontologies is a prior condition for diverse and efficient reasoning, and hence querying and hypothesis validation. Rigour allows a more consistent maintenance. Modelling such bio-ontologies is, however, a difficult task for bio-ontologists, because the necessary richness and rigour is difficult to achieve without extensive training.</p> <p>Results</p> <p>Analogous to design patterns in software engineering, Ontology Design Patterns are solutions to typical modelling problems that bio-ontologists can use when building bio-ontologies. They offer a means of creating rich and rigorous bio-ontologies with reduced effort. The concept of Ontology Design Patterns is described and documentation and application methodologies for Ontology Design Patterns are presented. Some real-world use cases of Ontology Design Patterns are provided and tested in the Cell Cycle Ontology. Ontology Design Patterns, including those tested in the Cell Cycle Ontology, can be explored in the Ontology Design Patterns public catalogue that has been created based on the documentation system presented (<url>http://odps.sourceforge.net/</url>).</p> <p>Conclusions</p> <p>Ontology Design Patterns provide a method for rich and rigorous modelling in bio-ontologies. They also offer advantages at different development levels (such as design, implementation and communication) enabling, if used, a more modular, well-founded and richer representation of the biological knowledge. This representation will produce a more efficient knowledge management in the long term.</p

Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene

Transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is a life-threatening disease caused by the abnormal production of misfolded TTR protein by liver cells, which is then released systemically. Its amyloid deposition in the heart is linked to cardiac toxicity and progression toward heart failure. A human induced pluripotent stem cell (iPSC) line was generated from peripheral blood mononuclear cells (PBMCs) from a patient suffering familial transthyretin amyloid cardiomyopathy carrying a c.128G>A (p.Ser43Asn) mutation in the TTR gene. This iPSC line offers a useful resource to study the disease pathophysiology and a cell-based model for therapeutic discovery

Detection of leukemic stem cell (CD26+) in patients with chronic myeloid leukemia with different molecular response

La leucemia mieloide crónica (LMC) se caracteriza por la t(9;22)(q34;q11), generando el gen de fusión BCR-ABL1 que codifica la oncoproteina P210 con actividad constitutiva de tirosina kinasa. Los pa-cientes que presentan una profunda y sostenida res-puesta molecular a los inhibidores de tirosina kinasa (ITK) pueden interrumpir el tratamiento. Sin em-bargo, aproximadamente el 50% de los casos presen-tan recurrencia molecular, probablemente debido a la persistencia de la stem cell leucémica (SCL) quies-cente (no replicativa, transcripcionalmente silente). Recientes publicaciones han demostrado que la ex-presión de la enzima dipeptidil peptidasa IV (CD26) está restringida a la fracción CD45+/CD34+/CD38- de la SCL en LMC y no se ha detectado en otras SCL mieloides/linfoides ni en medula ósea normal. Por esta razón CD26 es considerado un nuevo y especí-fico bio-marcador de LMC.El objetivo del trabajo fue detectar las SCL CD26+ en pacientes con LMC con diferente respuesta molecular (RM) y determinar si estas células persisten aun en casos con respuesta molecular profunda (RMP).Se analizaron 193 muestras de pacientes con LMC (107 sexo masculino y 86 femenino) para evaluar la SCL mediante citometría de flujo usando el panel de anticuerpos monoclonales: CD45, CD34, CD38, CD26, CD117, CD123, CD3 y HLA-DR. En para-lelo se realizó el estudio de la respuesta molecular mediante qRT-PCR BCR-ABL1 (Método Taqman). Ambos estudios se realizaron en simultáneo en la misma muestra, durante el seguimiento en diferen-tes momentos bajo tratamiento con ITK (imatinib, nilotinib o dasatinib). Los pacientes con una reducción de BCR-ABL1 ≥ a 3 log tenían una significativa menor proporción de casos con SCL CD26+ comparado con aquellos que tenían <3 log de reducción de los transcriptos (p<0.0003, OR: 3.4, 95% CI: 1,7 - 6,8). Consideran-do los 76 casos con RMP (33 RM4.0; 38 RM4.5 y 5 RM5.0), solamente 12/76 (16%) mostraron per-sistencia de la SCL CD26+. La presencia de la SCL CD26+ se redujo acorde aumenta la profundidad de la RM: 21%, 13% y 0% en RM4.0, RM4.5 y RM5.0 respectivamente. Nuestros resultados muestran que los pacientes con buena RM (≥3log), se asociaron con baja propor-ción de casos con SCL CD26+. Cuando la detección de SCL se evaluó exclusivamente en los casos con RMP, se observó que el decrecimiento de la SCL se asoció a mayor profundidad de la RM. La stem cell leucémica es altamente quiescente por lo cual podría estar presente aun en casos con respuesta molecular indetectable. En nuestro estudio la persistencia de SCL fue del 16% en casos con respuesta molecular profunda, indicando que la SCL persiste a pesar de la RM alcanzada. Este nuevo abordaje investigando la SCL podría ser útil en el seguimiento a largo plazo y de gran importancia en la evaluación de la recu-rrencia molecular en los casos incluidos en protoco-los de discontinuación.Chronic Myeloid Leukemia (CML) is characterized by the reciprocal translocation t(9;22)(q34;q21) resulting in the BCR-ABL1 fusion gene encoding the P210 oncoprotein with a constitutive tyrosine kinase (TK) activity. It is known that patients with at least two years in deep and sustained molecular response could stop TK inhibitor (TKI) treatment. However, half of them show molecular recurrence, probably due to the persistence of transcriptionally quiescent leukemic stem cells (LSC). Recent studies show that the expression of the enzyme dipeptidylpeptidase IV (CD26) is mainly restricted to the CD45+/CD34+/ CD38- fraction in CML LSC, and it is not found in other myeloid/lymphoid LSC or in normal bone marrow. For this reason, CD26 is considered a novel specific biomarker in CML. The aim of this study was to detect the CD26+ LSC in CML patients with different molecular responses (MR) and to assess if these cells remain even in deep molecular response (DMR). We have evaluated 193 CML patients (107 males and 86 females) for detection of LSC by flow cytometry using the panel: CD45, CD34, CD38, CD26, CD117, CD123, CD3 and HLA-DR and the BCR-ABL1 quantification by qRT-PCR (Taqman method). Both studies were carried out simultaneously on the same sample, during the follow up at different time points under TKI treatment (Imatinib, Nilotinib, Dasatinib). Patients with ≥ 3 BCR-ABL1 log reduction had a significantly lower percentage of cases with CD26+ LSC compared with those who had < 3 log reduction (p<0.0003, OR: 3.4, 95% CI: 1,7 - 6,8). Out of the 76 patients with DMR (33 in MR4.0, 38 in MR4.5 and 5 in MR5.0) only 12/76 (16%) showed persistence of CD26+ LSC. Furthermore, the presence of CD26+ LSC decreased accordingly to the achieved DMR: 21%, 13% and 0% in MR4.0, MR4.5 and MR5.0 respectively, without significant differences. Our results show that patients with good MR (≥3log) were significantly associated with a lower proportion of cases with LSC presence. When the LSC analysis was performed exclusively in cases with DMR, we observed that the decrease of LSC accompanied the deepness of the molecular response. Since the LSC is highly quiescent, it could be present even in cases with undetectable MR. In our study persistence of LSC in cases with DMR was 16%, indicating that these cells remain despite the MR achieved. This new approach to the study of the LSC could be useful in long-term follow-up and of great importance in the evaluation of molecular recurrence in cases included in discontinuation protocols.Fil: Bengio, R. M.. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex"; ArgentinaFil: Peña, M.. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex"; ArgentinaFil: Palacios, F.. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex"; ArgentinaFil: Moiraghi, B.. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; ArgentinaFil: Negri Aranguren, P.. Instituto Privado de Hematologia y Hemoterapia; ArgentinaFil: Enrico, A.. Hospital Italiano de La Plata; ArgentinaFil: Mariano, R.. Provincia de Entre Rios. Hospital San Martin; ArgentinaFil: Toloza, Maria Jazmin Ayelen. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Larripa, Irene Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentin

Resource description framework technologies in chemistry

ISSN:1758-294